The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.